These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 20848502

  • 1. Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine.
    Seksik P, Mary JY, Beaugerie L, Lémann M, Colombel JF, Vernier-Massouille G, Cosnes J.
    Inflamm Bowel Dis; 2011 Feb; 17(2):565-72. PubMed ID: 20848502
    [Abstract] [Full Text] [Related]

  • 2. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.
    Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M, Boureille A, Duclos B, Seksik P, Mary JY, Colombel JF.
    Gut; 2007 Oct; 56(10):1404-9. PubMed ID: 17504943
    [Abstract] [Full Text] [Related]

  • 3. Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.
    Musumba CO.
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1025-37. PubMed ID: 24099468
    [Abstract] [Full Text] [Related]

  • 4. The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.
    van Asseldonk DP, Jharap B, Verheij J, den Hartog G, Westerveld DB, Becx MC, Russel MG, Engels LG, de Jong DJ, Witte BI, Mulder CJ, van Nieuwkerk CM, Bloemena E, de Boer NK, van Bodegraven AA.
    Inflamm Bowel Dis; 2016 Sep; 22(9):2112-20. PubMed ID: 27482972
    [Abstract] [Full Text] [Related]

  • 5. Azathioprine induced nodular regenerative hyperplasia in IBD patients.
    Daniel F, Cadranel JF, Seksik P, Cazier A, Duong Van Huyen JP, Ziol M, Coutarel P, Loison P, Jian R, Marteau P.
    Gastroenterol Clin Biol; 2005 May; 29(5):600-3. PubMed ID: 15980758
    [Abstract] [Full Text] [Related]

  • 6. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.
    Seiderer J, Zech CJ, Diebold J, Schoenberg SO, Brand S, Tillack C, Göke B, Ochsenkühn T.
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):553-5. PubMed ID: 16607155
    [Abstract] [Full Text] [Related]

  • 7. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
    Ferlitsch A, Teml A, Reinisch W, Ulbrich G, Wrba F, Homoncik M, Gangl A, Peck-Radosavljevic M, Vogelsang H.
    Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
    [Abstract] [Full Text] [Related]

  • 8. Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
    Seinen ML, van Asseldonk DP, de Boer NK, Bouma G, van Nieuwkerk CM, Mulder CJ, Bloemena E, van Bodegraven AA.
    Inflamm Bowel Dis; 2017 Mar; 23(3):448-452. PubMed ID: 28151736
    [Abstract] [Full Text] [Related]

  • 9. The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients.
    Gilissen LPL, Tajzai R, Romberg M, Pierik M, Stronkhorst A, Steenhuisen K, Van Bodegraven A, Daniels A, Wong D.
    Eur J Gastroenterol Hepatol; 2021 Dec 01; 33(1S Suppl 1):e102-e107. PubMed ID: 33136726
    [Abstract] [Full Text] [Related]

  • 10. Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature.
    Dooremont D, Decaestecker J, De Wulf D, Ghillebert G, Van Vlierberghe H, Van Dorpe J, Baert F.
    Acta Gastroenterol Belg; 2013 Sep 01; 76(3):342-6. PubMed ID: 24261031
    [Abstract] [Full Text] [Related]

  • 11. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?].
    Ehmsen L, Marko C, Breidert M.
    Dtsch Med Wochenschr; 2008 May 01; 133(18):950-3. PubMed ID: 18431703
    [Abstract] [Full Text] [Related]

  • 12. Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia.
    De Boer NK, Tuynman H, Bloemena E, Westerga J, Van Der Peet DL, Mulder CJ, Cuesta MA, Meuwissen SG, Van Nieuwkerk CM, Van Bodegraven AA.
    Scand J Gastroenterol; 2008 May 01; 43(5):604-8. PubMed ID: 18415755
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom.
    Bayoumy AB, van Liere ELSA, Simsek M, Warner B, Loganayagam A, Sanderson JD, Anderson S, Nolan J, de Boer NK, Mulder CJJ, Ansari A.
    BMC Gastroenterol; 2020 Sep 11; 20(1):296. PubMed ID: 32917155
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.
    Barge S, Grando V, Nault JC, Broudin C, Beaugrand M, Ganne-Carrié N, Roulot D, Ziol M.
    Liver Int; 2016 Jul 11; 36(7):1059-66. PubMed ID: 26415006
    [Abstract] [Full Text] [Related]

  • 15. Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients.
    Simsek M, Meijer B, Ramsoekh D, Bouma G, van der Wouden EJ, den Hartog B, de Vries AC, Hoentjen F, Dijkstra G, de Boer SY, Jansen JM, van der Meulen AE, Beukers R, Brink MA, Steinhauser T, Oldenburg B, Gilissen LP, Naber TH, Verhagen MA, de Boer NKH, Mulder CJJ, Dutch Initiative on Crohn and Colitis (ICC).
    Clin Gastroenterol Hepatol; 2019 Feb 11; 17(3):568-570. PubMed ID: 29775790
    [Abstract] [Full Text] [Related]

  • 16. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
    Schumann M, Preiss JC, Loddenkemper C, Günther U, Somasundaram R, Siegmund B, Zeitz M.
    Dtsch Med Wochenschr; 2008 Sep 11; 133(38):1897-900. PubMed ID: 18788068
    [Abstract] [Full Text] [Related]

  • 17. A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.
    Teml A, Schwab M, Hommes DW, Almer S, Lukas M, Feichtenschlager T, Florin T, Seiderer J, Petritsch W, Bokemeyer B, Kreisel W, Herrlinger KR, Knoflach P, Bonaz B, Klugmann T, Herfarth H, Pedarnig N, Reinisch W.
    Wien Klin Wochenschr; 2007 Sep 11; 119(17-18):519-26. PubMed ID: 17943403
    [Abstract] [Full Text] [Related]

  • 18. Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
    Błogowski W, Marlicz W, Smereczyński A, Lawniczak M, Lewosiuk A, Starzyńska T.
    Immunopharmacol Immunotoxicol; 2011 Jun 11; 33(2):398-402. PubMed ID: 20726808
    [Abstract] [Full Text] [Related]

  • 19. Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
    Soh JS, Yun WJ, Kim KJ, Won CH, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Kim JH.
    Inflamm Bowel Dis; 2015 Apr 11; 21(4):832-9. PubMed ID: 25789922
    [Abstract] [Full Text] [Related]

  • 20. Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience.
    Macaluso FS, Renna S, Maida M, Dimarco M, Sapienza C, Affronti M, Orlando E, Rizzuto G, Orlando R, Ventimiglia M, Cottone M, Orlando A.
    Scand J Gastroenterol; 2017 Sep 11; 52(9):981-987. PubMed ID: 28554266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.